259 related articles for article (PubMed ID: 19702493)
21. Neuroleptic rechallenge after neuroleptic malignant syndrome: case report and literature review.
Wells AJ; Sommi RW; Crismon ML
Drug Intell Clin Pharm; 1988 Jun; 22(6):475-80. PubMed ID: 2899492
[TBL] [Abstract][Full Text] [Related]
22. [Neuroleptic malignant syndrome].
Murak E
Psychiatr Pol; 1995; 29(3):349-58. PubMed ID: 7652088
[TBL] [Abstract][Full Text] [Related]
23. Progression of symptoms in neuroleptic malignant syndrome.
Velamoor VR; Norman RM; Caroff SN; Mann SC; Sullivan KA; Antelo RE
J Nerv Ment Dis; 1994 Mar; 182(3):168-73. PubMed ID: 7906709
[TBL] [Abstract][Full Text] [Related]
24. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.
Perry PJ; Wilborn CA
Ann Clin Psychiatry; 2012 May; 24(2):155-62. PubMed ID: 22563571
[TBL] [Abstract][Full Text] [Related]
25. [Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report].
Erol A; Putgül G; Sert E; Mete L
Turk Psikiyatri Derg; 2013; 24(2):140-4. PubMed ID: 23754268
[TBL] [Abstract][Full Text] [Related]
26. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death.
Tural U; Onder E
Psychiatry Clin Neurosci; 2010 Feb; 64(1):79-87. PubMed ID: 20416027
[TBL] [Abstract][Full Text] [Related]
27. Neuroleptic malignant syndrome and its controversies.
Margetić B; Aukst-Margetić B
Pharmacoepidemiol Drug Saf; 2010 May; 19(5):429-35. PubMed ID: 20306454
[TBL] [Abstract][Full Text] [Related]
28. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.
Trollor JN; Chen X; Sachdev PS
CNS Drugs; 2009; 23(6):477-92. PubMed ID: 19480467
[TBL] [Abstract][Full Text] [Related]
29. Neuroleptic malignant syndrome: a report of a case and review of the literature.
Kanchanapongkul J
J Med Assoc Thai; 1991 Oct; 74(10):481-4. PubMed ID: 1686780
[TBL] [Abstract][Full Text] [Related]
30. Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.
Belvederi Murri M; Guaglianone A; Bugliani M; Calcagno P; Respino M; Serafini G; Innamorati M; Pompili M; Amore M
Drugs R D; 2015 Mar; 15(1):45-62. PubMed ID: 25578944
[TBL] [Abstract][Full Text] [Related]
31. Examining the Features of Neuroleptic Malignant Syndrome in Anti-NMDA Receptor Encephalitis: A Case-Control Study.
Ramirez-Bermudez J; Restrepo-Martinez M; Espinola-Nadurille M; Martinez-Angeles V; Lopez-Hernandez JC; Hernandez-Vanegas LE; Martinez-Carrillo F; Ruiz-Garcia R; Rivas-Alonso V; Flores-Rivera J; Pollak TA
J Acad Consult Liaison Psychiatry; 2024; 65(3):222-230. PubMed ID: 38151160
[TBL] [Abstract][Full Text] [Related]
32. [The Neuroleptic Malignant Syndrome].
Nagel M; Freisberg S; Junghanns K; Moll CK; Willenborg B
Fortschr Neurol Psychiatr; 2015 Jul; 83(7):373-80. PubMed ID: 26200042
[TBL] [Abstract][Full Text] [Related]
33. Neuroleptic Malignant Syndrome.
Pileggi DJ; Cook AM
Ann Pharmacother; 2016 Nov; 50(11):973-981. PubMed ID: 27423483
[TBL] [Abstract][Full Text] [Related]
34. Neuroleptic malignant syndrome associated with atypical antipsychotics: A case report.
Mogollon Díaz JP; Lizcano Toloza LY; Serrano García AY; Alquichire Luna CA; García Bohorquez DF; Chaparro Durán MF; Cáceres Valero MV
Rev Colomb Psiquiatr (Engl Ed); 2023; 52(1):78-81. PubMed ID: 37031016
[TBL] [Abstract][Full Text] [Related]
35. Neuroleptic malignant syndrome: two cases without muscle rigidity.
Wong MM
Aust N Z J Psychiatry; 1996 Jun; 30(3):415-8. PubMed ID: 8839955
[TBL] [Abstract][Full Text] [Related]
36. Acute Dystonia Versus Neuroleptic Malignant Syndrome Without Fever in an Eight-Year-Old Child.
Sridaran R; Nesbit CE
Pediatr Emerg Care; 2017 Jan; 33(1):38-40. PubMed ID: 28045840
[TBL] [Abstract][Full Text] [Related]
37. Atypical neuroleptic malignant syndrome - A case report.
Vellekkatt F; Kuppili PP; Bharadwaj B; Menon V
Asian J Psychiatr; 2019 Jun; 43():7-8. PubMed ID: 31071486
[TBL] [Abstract][Full Text] [Related]
38. Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective.
Tse L; Barr AM; Scarapicchia V; Vila-Rodriguez F
Curr Neuropharmacol; 2015; 13(3):395-406. PubMed ID: 26411967
[TBL] [Abstract][Full Text] [Related]
39. Massive asymptomatic creatine kinase elevation in youth during antipsychotic drug treatment: case reports and critical review of the literature.
Masi G; Milone A; Viglione V; Mancini A; Pisano S
J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):536-42. PubMed ID: 25387323
[TBL] [Abstract][Full Text] [Related]
40. Neuroleptic malignant syndrome during a change from haloperidol to risperidone.
Reeves RR; Mack JE; Torres RA
Ann Pharmacother; 2001 Jun; 35(6):698-701. PubMed ID: 11408988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
